ReShape Lifesciences signs license agreement with Biorad Medisys for Obalon Gastric BalloonReShape Lifesciences has signed an exclusive, royalty-bearing license agreement with Biorad Medysis (Biorad) to manufacture,...
22 states in the US have an adult obesity prevalence at or above 35%New population data from 2022 show 22 states have an adult obesity prevalence at or above 35%, compared to 19 states in 2021, according...
SOS: Lower risk of haematological cancer after bariatric surgeryBariatric surgery is associated with a reduced incidence of haematological cancer, specifically in women, according to the latest...
New model for in vitro production of human brown fat cells A team led by investigators at Brigham and Women's Hospital has identified a set of cellular signalling cues that lead up to brown...
ReShape strengthens patent portfolio related to its Obalon Balloon SystemReShape Lifesciences has strengthened the patent portfolio related to its Obalon Balloon System, after to US Patent and Trademark Office...
EMA grants Orphan Drug Designation for Setmelanotide for treatment of acquired hypothalamic obesityThe European Medicines Agency (EMA) has issued a positive opinion on the Rhythm Pharmaceuticals’ orphan drug designation request for...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment4 days ago